Skip to main content
. 2020 Oct 10;9(23):8931–8939. doi: 10.1002/cam4.3516

Figure 3.

Figure 3

Cumulative incidence of chronic myeloid leukemia (CML)‐related deaths stratified by the scoring systems, according to initial therapy. The prognoses of patients initially treated with imatinib (A) and with second‐generation tyrosine kinase inhibitor (B) were stratified by the Sokal, Hasford, European Treatment and Outcome Study (EUTOS), and EUTOS long‐term survival (ELTS) score, respectively